Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
A team led by Kirill Afonin at UNC Charlotte engineered programmable DNA scaffolds that organize silver nanoclusters into highly potent antimicrobial agents. The spatially arranged DNA‑AgNCs showed up to 78‑fold greater killing efficiency against ESKAPE pathogens and meningitis‑causing bacteria compared with standard antibiotics. Cytosine‑rich hairpin designs (C13) and multivalent DNA architectures delivered high local silver concentrations while remaining fluorescent for real‑time tracking. In mouse osteoblast models, the nanoclusters eradicated intracellular Staphylococcus aureus with minimal mammalian toxicity.
Glenmark Pharmaceuticals has launched GLIPIQ, a semaglutide‑based GLP‑1 therapy, in India following CDSCO approval after a local Phase III study. The product is offered in both vial‑with dose‑specific syringes and pre‑filled pen formats, covering 2 mg, 4 mg and 8 mg strengths. Pricing is...
Researchers at Texas A&M Health discovered that the fibroblast growth factor receptor 1 (FGFR1) drives cholesterol accumulation in prostate cancer cells by activating the sterol regulatory element‑binding protein 2 (SREBP2). This signaling cascade up‑regulates LDL‑receptor (LDLR) and cholesterol‑synthesis enzymes, boosting intracellular cholesterol...
When I was talking to Sergiy Velychko, a former postdoc from George Church's lab, about the future of human genome engineering, we discussed: “We're now at this point where we can engineer ourselves. We can do stem cell therapies. We can...
Aelis Farma announced that recruitment has begun for its Phase 2B trial of AEF0217, a first‑in‑class signalling‑specific CB1 receptor inhibitor, aimed at treating behavioral and cognitive impairments in Down syndrome. The study will enroll 188 participants aged 16‑32 across ten...
Celebrating another week of amazing progress at the Sinclair lab and farewell to a couple of our beloved students, Yifan and Hanyu, both headed off to graduate school 👩🏻🎓 This morning we had our usual three hour lab meeting, but it...
Fun fact: in 2008, when we published that NAD-dependent SIRT1 suppresses cancer, almost no one believed us. How could a longevity gene suppress cancer? they asked https://t.co/aPAG3zf470
Australia will introduce FluMist, a needle‑free nasal flu vaccine for children aged 2‑17, this winter. The live‑attenuated spray targets the upper respiratory tract and offers protection comparable to injectable shots, reducing flu cases by 40‑60%. It will be free for...
It's studies like this why I treat supplements are a secondary, and last resort, not a primary approach Senolytic treatment induces oligodendrocyte dysfunction and demyelination in the corpus callosum https://t.co/t3jMFTcKcL
GlaxoSmithKline (GSK) announced FDA approval for Lynavoy, the first U.S. drug targeting cholestatic pruritus in adults with primary biliary cholangitis (PBC). The decision rests on Phase 3 GLISTEN trial data showing rapid, sustained itch relief and improved sleep, marking the...
A new study delivers a comprehensive single‑cell transcriptomic atlas of microglia from multiple Alzheimer’s disease mouse models. By profiling thousands of cells, researchers uncovered diverse microglial states, including disease‑associated subtypes linked to TREM2 signaling and amyloid pathology. The atlas integrates...
The study reveals that the long non‑coding RNA LINC01116 is markedly up‑regulated in metastatic osteosarcoma and directly binds the urea‑cycle enzyme CPS1. Disruption of the LINC01116‑CPS1 interaction impairs citrulline production, indicating a compromised urea cycle, and markedly suppresses tumor proliferation...
Seriously? I make low-cost vaccines that reached 100 million people, bypassed big pharma, didn’t make a dime, and saved 300,000-500,000 lives, and they focus on a junk food joke I made 6 years ago, this Rogan crowd, a bunch of...
On February 15, 2012, the FDA announced that Bracco Diagnostics’ CardioGen‑82 generator will re-enter the U.S. market after a voluntary recall in July 2011. The agency approved revised labeling that introduces a Boxed Warning and new “Alert Limits” for strontium‑82...
The FDA has revised the Tysabri (natalizumab) label to detail progressive multifocal leukoencephalopathy (PML) risk based on infusion count and prior immunosuppressant exposure. Data show 102 PML cases among 82,732 treated patients, with incidence rising sharply after 24 infusions. A...
The FDA has granted clearance for Siemens Healthineers’ Varian radiotherapy platforms—including TrueBeam, TrueBeam STx, VitalBeam and Edge—to treat medically refractory osteoarthritis in adults. Low‑dose radiation therapy offers a non‑invasive alternative to steroid injections, physical therapy, and ultimately joint replacement surgery...
A recent multicenter trial compared letrozole‑based protocols with traditional GnRH antagonist regimens for women experiencing ovarian aging undergoing IVF. The study found that letrozole reduced total gonadotropin dose and improved mature oocyte yield without compromising clinical pregnancy rates. GnRH antagonists...
EyePoint Therapeutics filed a lawsuit in Massachusetts accusing rival Ocular Therapeutix of spreading false and misleading statements about EyePoint’s lead experimental eye drug, Duravyu. The complaint alleges defamation, commercial disparagement, consumer‑protection violations, and interference with business relationships. EyePoint seeks a...
Researchers at HKUST have created CarGAP, a chemo‑optogenetic system that couples vitamin B₁₂ binding with green‑light activation to toggle gap junctions on and off. In the dark, vitamin B₁₂ induces oligomerization of a bacterial CarHC domain, physically blocking connexin or innexin channels;...
Identification of a Novel Drug Sensitivity Biomarker Neuregulin-2 for Venetoclax in Non-t(11;14) Multiple Myeloma [Dec 12, 2021] Dai et al. Abstract 459 #ASH21 https://t.co/mnXEThuKgy #mmsm #PrecisionMedicine https://t.co/zx7d29Jzpk
ImmunityBio secured its first Asian regulatory clearance as the Macau Special Administrative Region approved ANKTIVA® for BCG‑unresponsive non‑muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The decision leveraged prior FDA and EMA approvals, illustrating a...
LazySlide is an open‑source Python package built on the scverse ecosystem that streamlines whole‑slide image analysis and multimodal integration. It partitions massive pathology slides into manageable patches, applies foundation AI models to extract visual features, and directly links those features...
Cellular health depends on rigorous quality control of messenger RNA, yet these surveillance pathways weaken with age. Research in C. elegans and yeast shows that impaired nonsense‑mediated decay, nonstop decay, and no‑go decay lead to ribosome stalling, protein aggregation, and...
Researchers at the University of Erlangen‑Nuremberg successfully revived neuronal activity in vitrified mouse brain slices after cryogenic storage. Using rapid cooling to –320 °F, they preserved synaptic membranes and long‑term potentiation for up to seven days. Electrical testing showed largely normal...
Researchers at Florida Atlantic University discovered that the protein Rhes teams up with the bicarbonate transporter SLC4A7 to build tunneling nanotubes (TNTs) that ferry mutant huntingtin (mHTT) between neurons. Disrupting this Rhes‑SLC4A7 axis in mice dramatically curbed intercellular spread of...
The FDA has granted first‑line approval for a nivolumab‑plus‑AVD regimen in patients aged 12 and older with stage III‑IV classical Hodgkin lymphoma. The decision follows the phase 3 SWOG S1826 trial, which showed a 58% progression‑free survival rate and a hazard ratio of...
The FDA granted accelerated approval to Wegovy HD, a 7.2 mg weekly semaglutide injection, marking the fourth product cleared under the National Priority Voucher pilot. Phase 3 STEP UP data showed a mean 20.7% weight loss, with nearly one‑third of participants shedding 25% or...
The Indian Council of Agricultural Research’s Veterinary Research Institute (ICAR‑IVRI) has produced the first indigenous Sahiwal calves using ultrasound‑guided ovum pick‑up, in‑vitro fertilisation and embryo transfer (OPU‑IVF‑ET). Within five days in February‑March 2026, five healthy calves were born from a...
A real‑world propensity‑matched study of 1,666 non‑diabetic patients found that initiating tirzepatide within 14 days of an acute myocardial infarction or ischemic stroke cut the risk of emergency‑room visits, hospitalizations, acute kidney injury, repeat stroke and heart‑failure admission over two...
Researchers at Nectome have successfully cryopreserved an entire pig brain, locking cellular activity with minimal damage. The method uses rapid vitrification to prevent ice formation, preserving neural architecture and synaptic connections. Nectome now plans to offer the service to terminally...
Direct‑to‑consumer pharmacogenomic testing is rapidly expanding in the UK despite the absence of a dedicated regulatory framework. A 2021 parliamentary inquiry called for stronger safeguards, but these have not been applied to PGx services. Researchers conducted focus groups with consumers...
The FDA released a series of updates between 2020 and 2026 that revise, recognize, or withdraw antimicrobial susceptibility breakpoints and standards for dozens of drugs. Recent actions include recognizing M100 MIC and disk‑diffusion breakpoints for amikacin, cefiderocol, and several beta‑lactam...
The March 20, 2026 "In the Clinic" page aggregates a wide array of BioWorld snapshots, special reports, and infographics covering biopharma, medical technology, and emerging therapeutic areas. It links to daily data snapshots, market outlooks, and deep‑dive analyses such as the med‑tech...
Robots Made From Living Cells Get Upgraded With Their Very Own Nervous Systems https://t.co/ctQ64b45O4 https://t.co/ye1TV6VwCn
Indian drugmakers Natco Pharma, Glenmark Pharmaceuticals and Eris Lifesciences are set to launch generic semaglutide on March 23, 2026, just after the drug’s patent expired. The generics are priced roughly 80% less than Novo Nordisk’s Ozempic, with Natco’s vials costing...
Earendil Labs announced a $787 million financing round, the largest recent capital raise for AI‑enabled drug development. The funding, led by Sanofi and the Biotech Development Fund, will be used to scale its AI‑driven biologics discovery platform, expand R&D teams, and...
Idiopathic pulmonary fibrosis (IPF) treatment now includes three FDA‑approved antifibrotic drugs—nerandomilast, nintedanib, and pirfenidone—each shown to slow forced vital capacity decline. Nerandomilast, approved in 2025, marks the first new IPF therapy in over a decade, while cost‑effectiveness analyses favor nintedanib...
Imatinib (Gleevec®/Glivec®) is an oral ATP‑competitive inhibitor of the BCR‑ABL fusion tyrosine kinase, approved by the FDA in 2001 for Philadelphia chromosome‑positive chronic myeloid leukemia and other malignancies. The drug emerged from high‑throughput screening, structure‑activity relationship optimization, and structure‑based drug...
This is a recurrent fiasco. Health care companies that now the serious risk of their device or drug but keep selling it and do not acknowledge the hazard. Until so many people are harmed. Today's front page @nytimes by @katie_thomas @bostonsci...
A new Nature study of 450,000 people finds that the APOE gene, particularly the APOE3 and APOE4 variants, accounts for 72‑93% of Alzheimer’s disease cases, and that 99% of the population carries at least one risk‑increasing allele. Lexeo Therapeutics is...
The UK’s National Institute for Health and Care Excellence (NICE) has reopened its evaluation of Eli Lilly’s donanemab and Eisai’s lecanemab after initially rejecting them on cost grounds. A newly‑introduced cost‑effectiveness threshold of roughly £20,000 per quality‑adjusted life year (QALY)...
This week's Readout LOUD podcast is now available on all your favorite podcast outlets -- Stelios Papadopolous, the ‘godfather’ of biotech, in conversation with @damiangarde https://t.co/RHh5Qv9OyT via @statnews
Polycomb repressive-deubiquitinase complex safeguards oocyte epigenome and female fertility by restraining Polycomb activity https://t.co/M6JjHH2JG2 https://t.co/dnHknjJmJy
Novartis announced a deal worth up to $3 billion to acquire SNV4818, a pan‑mutant‑selective PI3Kα inhibitor aimed at hormone‑receptor‑positive, HER2‑negative breast cancer. The transaction includes $2 billion upfront and potential milestones exceeding $1 billion, with closing expected in early 2026. Collegium Pharmaceutical agreed...
Researchers engineered the heterotrophic microalga Prototheca moriformis to produce high levels of polymethylene octadecanoic acid (POA), achieving over 50% POA of total fatty acids and roughly 20.8 g/L POA in a 1 L fed‑batch fermentation. The study, funded by Nestlé and Checkerspot,...
Georgia Tech researchers have unveiled a cell‑free biocatalytic platform that converts carbon dioxide into the amino acids serine and glycine with a 97% yield, the highest efficiency reported for any synthetic‑biology system. By introducing heat‑tolerant enzymes from Moorella thermoacetica and...
Why should tumor whole genome sequencing (WGS) be done for cancer? In real practice of medicine study of 888 patients with solid cancers, WGS directly led to clinical consequences in over 40% @NatureMedicine https://t.co/kFho0yuLS7
Giant biotech round that hit right after I sent Pro Rata: Earendil Labs raises $787M https://t.co/NWt2bBA9Lr
The Longevity Lifehacks series compiles a dense timeline of cutting‑edge research from early 2024 through March 2026, spanning neurodegeneration, immune modulation, and metabolic interventions. Highlights include CAR‑T cell engineering for Alzheimer’s plaque clearance, photobiomodulation to boost T‑cell responses, and multiple...
AI to understand the language of life. Our review @NatureBiotech just published https://t.co/i0WMaXBCHl Free access https://t.co/3LPulNxlD0 @VishRao5 @serena2z @BrianPlosky @pdhsu @BoWang87 @james_y_zou @marinkazitnik @pranavrajpurkar
